CD40LG and atherosclerosis: Notably, murine IgM anti-PC have been demonstrated to inhibit toll-like receptor (TLR)-mediated inflammation [45]–[47], suppress disease in murine models of inflammatory arthritis [45] and halt the progression of atherosclerosis in hypercholesterolemic mice [48].